Heron Therapeutics (Heron Therapeutics) Days Inventory : 388.25 (As of Dec. 2023)

View and export this data going back to 1987. Start your Free Trial

What is Heron Therapeutics Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Heron Therapeutics's Average Total Inventories for the three months ended in Dec. 2023 was $42.1 Mil. Heron Therapeutics's Cost of Goods Sold for the three months ended in Dec. 2023 was $9.9 Mil. Hence, Heron Therapeutics's Days Inventory for the three months ended in Dec. 2023 was 388.25.

The historical rank and industry rank for Heron Therapeutics's Days Inventory or its related term are showing as below:

HRTX' s Days Inventory Range Over the Past 10 Years
Min: 189.55 Med: 339.83 Max: 55688.57
Current: 263.91

During the past 13 years, Heron Therapeutics's highest Days Inventory was 55688.57. The lowest was 189.55. And the median was 339.83.

HRTX's Days Inventory is ranked worse than
62.06% of 651 companies
in the Biotechnology industry
Industry Median: 189.69 vs HRTX: 263.91

Heron Therapeutics's Days Inventory increased from Dec. 2022 (385.94) to Dec. 2023 (388.25). It might indicate that Heron Therapeutics's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Heron Therapeutics's Inventory Turnover for the three months ended in Dec. 2023 was 0.24.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Heron Therapeutics's Inventory-to-Revenue for the three months ended in Dec. 2023 was 1.23.

Heron Therapeutics Days Inventory Historical Data

The historical data trend for Heron Therapeutics's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heron Therapeutics Days Inventory Chart

Heron Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

Get a 7-Day Free Trial

189.55

337.24

358.04

342.41

271.02

Heron Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Inventory	Get a 7-Day Free Trial															385.94	288.66	218.83	217.07	388.25

Competitive Comparison of Heron Therapeutics's Days Inventory

For the Biotechnology subindustry, Heron Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Heron Therapeutics's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Heron Therapeutics's Days Inventory distribution charts can be found below:

* The bar in red indicates where Heron Therapeutics's Days Inventory falls into.

Heron Therapeutics Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Heron Therapeutics's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (54.573	+	42.11)	/	2 )	/	65.105	*	365
=	48.3415					/	65.105	*	365
=	271.02

Heron Therapeutics's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (42.007	+	42.11)	/	2 )	/	9.885	*	365 / 4
=	42.0585					/	9.885	*	365 / 4
=	388.25

Heron Therapeutics (NAS:HRTX) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Heron Therapeutics's Inventory Turnover for the three months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	9.885	/	42.0585
	=	0.24

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Heron Therapeutics's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	42.0585	/	34.233
	=	1.23

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Heron Therapeutics Days Inventory Related Terms

Thank you for viewing the detailed overview of Heron Therapeutics's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Heron Therapeutics (Heron Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heron Therapeutics Inc (NAS:HRTX) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

AXD2:Germany AXD2:Germany

Address

4242 Campus Point Court, Suite 200, San Diego, CA, USA, 92121

Website

https://www.herontx.com

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011.

Executives

William P Forbes	officer: EVP, Chief Development Officer	C/O SALIX PHARMACEUTICALS, LTD., 8510 COLONNADE CENTER DRIVE, RALEIGH NC 27615
Adam Morgan	other: See Footnote 2	1055B POWERS PLACE, ALPHARETTA GA 30009
Ira Duarte	officer: EVP, Chief Financial Officer	1255 CRESCENT GREEN DRIVE, SUITE 250, CARY NC 27518
Craig A Collard	director	C/O CORNERSTONE THERAPEUTICS INC., 1255 CRESCENT GREEN DRIVE, SUITE 250, CARY NC 27518
Kevin Kotler	director	C/O BROADFIN CAPITAL, LLC, 300 PARK AVENUE, 25TH FLOOR, NEW YORK NY 10022
Velan Capital Master Fund Lp	other: See Footnote 2	1055B POWERS PLACE, ALPHARETTA GA 30009
Velan Capital Management Llc	other: See Footnote 2	1055B POWERS PLACE, ALPHARETTA GA 30009
Velan Capital Holdings Llc	other: See Footnote 2	1055B POWERS PLACE, ALPHARETTA GA 30009
Velan Capital Investment Management Lp	other: See Footnote 2	1055B POWERS PLACE, ALPHARETTA GA 30009
David Efraim Rosen	other: See Footnote 1	155 EAST 44TH ST., SUITE 1630, NEW YORK NY 10017
Rubric Capital Management Lp	other: See Footnote 1	155 EAST 44TH ST, SUITE 1630, NEW YORK NY 10017
Balaji Venkataraman	other: See Footnote 2	FIRST HORIZON PHARMACEUTICAL CORP, 660 HEMBREE PKWY STE 106, ROSWELL GA 30076
Kimberly Manhard	director	C/O HERON THERAPEUTICS, INC, 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO CA 92121
Craig A Johnson	director	C/O PURE BIOSCIENCE, 1725 GILLESPIE WAY, EL CAJON CA 92020
Waage Christian	director	RECEPTOS, INC., 10835 ROAD TO THE CURE, SUITE 205, SAN DIEGO CA 92121